• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有川崎病病史的父母,其孩子也患有同样的疾病。

Parents with a history of Kawasaki disease whose child also had the same disease.

作者信息

Uehara Ritei, Yashiro Mayumi, Nakamura Yosikazu, Yanagawa Hiroshi

机构信息

Department of Public Health, Jichi Medical University, Tochigi, Japan.

出版信息

Pediatr Int. 2011 Aug;53(4):511-4. doi: 10.1111/j.1442-200X.2010.03267.x.

DOI:10.1111/j.1442-200X.2010.03267.x
PMID:21040190
Abstract

BACKGROUND

The aim of this study was to describe time trends of prevalence and detailed characteristics of parents with a history of Kawasaki disease (KD) who had a child with the same disease using data from Japanese nationwide surveys on KD.

METHODS

Parents with a history of KD were identified using nationwide surveys of KD patients who visited hospitals between 1999 and 2008. To confirm KD histories, a parental questionnaire was sent to pediatricians who reported parental cases to the surveys for KD patients who visited hospitals from 2001 through 2004. Parental history was ascertained by merging data from the parental questionnaire with data from previous nationwide surveys, and detailed information about childhood KD was obtained from survey reports.

RESULTS

During the 10-year study period, 407 parents with a child with KD were reported as having a KD history (0.43%). The prevalence of such parents significantly increased during this study period (regression coefficient: 0.13, 95% confidence interval: 0.05-0.20). Thirty-one confirmed parents with the history were diagnosed between 1966 and 1984. All parents met the case definition of KD, and 33% had been treated with steroids. No parent with a KD history received intravenous immunoglobulin (IVIG).

CONCLUSIONS

The prevalence of parents with KD history with a child with the same disease increased during the study period. Some of these parents had not been treated with IVIG because they were diagnosed before its use was widespread in Japan. An increase in the number of parents with the history is expected, thus continuous monitoring of familial cases with KD is required.

摘要

背景

本研究旨在利用日本全国川崎病(KD)调查数据,描述有KD病史且其子女也患同病的父母的患病率时间趋势及详细特征。

方法

通过对1999年至2008年期间到医院就诊的KD患者进行全国性调查,确定有KD病史的父母。为确认KD病史,向在2001年至2004年期间到医院就诊的KD患者调查中报告父母病例的儿科医生发送了一份家长问卷。通过将家长问卷数据与之前全国性调查的数据合并来确定家长病史,并从调查报告中获取有关儿童KD的详细信息。

结果

在10年研究期间,报告有407名有KD患儿的父母有KD病史(0.43%)。在此研究期间,这类父母的患病率显著增加(回归系数:0.13,95%置信区间:0.05 - 0.20)。31名确诊有该病史的父母在1966年至1984年期间被诊断。所有父母均符合KD病例定义,33%曾接受类固醇治疗。没有有KD病史的父母接受过静脉注射免疫球蛋白(IVIG)治疗。

结论

在研究期间,有KD病史且其子女也患同病的父母的患病率有所增加。其中一些父母未接受IVIG治疗是因为他们在日本IVIG广泛使用之前就被诊断了。预计有该病史的父母数量会增加,因此需要持续监测KD家族病例。

相似文献

1
Parents with a history of Kawasaki disease whose child also had the same disease.有川崎病病史的父母,其孩子也患有同样的疾病。
Pediatr Int. 2011 Aug;53(4):511-4. doi: 10.1111/j.1442-200X.2010.03267.x.
2
Clinical features of patients with Kawasaki disease whose parents had the same disease.父母患有川崎病的川崎病患者的临床特征。
Arch Pediatr Adolesc Med. 2004 Dec;158(12):1166-9. doi: 10.1001/archpedi.158.12.1166.
3
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.日本川崎病患者对初始静脉注射免疫球蛋白治疗无反应的潜在风险因素分析。
Pediatr Infect Dis J. 2008 Feb;27(2):155-60. doi: 10.1097/INF.0b013e31815922b5.
4
Low risk of treatment resistance in Down syndrome with Kawasaki disease.唐氏综合征合并川崎病时治疗抵抗风险较低。
Pediatr Int. 2017 Dec;59(12):1236-1239. doi: 10.1111/ped.13429.
5
Clinical Characteristics of Patients With Kawasaki Disease Whose Siblings Had the Same Disease.川崎病患儿同胞患病的临床特征。
Pediatr Infect Dis J. 2021 Jun 1;40(6):531-536. doi: 10.1097/INF.0000000000003074.
6
The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan.川崎病早期静脉注射免疫球蛋白治疗效果:日本第 22 次全国调查。
Int J Cardiol. 2018 Oct 15;269:334-338. doi: 10.1016/j.ijcard.2018.07.092. Epub 2018 Jul 19.
7
Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008.蒙古的川崎病:1996-2008 年两项全国性回顾性调查结果。
J Epidemiol. 2011;21(4):293-8. doi: 10.2188/jea.je20100144. Epub 2011 Jun 18.
8
Kawasaki disease in parents and children.父母与子女中的川崎病。
Acta Paediatr. 2003 Jun;92(6):694-7. doi: 10.1080/08035320310002768.
9
Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.2015 - 2016年日本川崎病全国流行病学调查
Pediatr Int. 2019 Apr;61(4):397-403. doi: 10.1111/ped.13809. Epub 2019 Apr 16.
10
Five years of Kawasaki disease in the Netherlands: a national surveillance study.荷兰川崎病五年:一项全国性监测研究。
Pediatr Infect Dis J. 2014 Aug;33(8):793-7. doi: 10.1097/INF.0000000000000271.

引用本文的文献

1
polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population.在南方汉族人群中,川崎病患者的多态性(rs7251246 T > C)、冠状动脉瘤和血栓形成。
Front Immunol. 2023 Jun 19;14:1184162. doi: 10.3389/fimmu.2023.1184162. eCollection 2023.
2
Association of Familial History of Diabetes, Hypertension, Dyslipidemia, Stroke, or Myocardial Infarction With Risk of Kawasaki Disease.家族糖尿病史、高血压史、血脂异常史、卒中史或心肌梗死史与川崎病风险的相关性。
J Am Heart Assoc. 2022 Jun 21;11(12):e023840. doi: 10.1161/JAHA.121.023840. Epub 2022 Jun 14.
3
Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.
我们对川崎病发病机制的不断认识:肠道微生物群的作用。
Front Immunol. 2020 Jul 24;11:1616. doi: 10.3389/fimmu.2020.01616. eCollection 2020.
4
Kawasaki-like disease in children with COVID-19: A hypothesis.儿童 COVID-19 相关川崎样疾病:一种假说。
Med Hypotheses. 2020 Oct;143:110117. doi: 10.1016/j.mehy.2020.110117. Epub 2020 Jul 18.
5
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.川崎病:意大利儿科学会指南,第一部分-定义、流行病学、病因发病机制、急性期临床表现和治疗。
Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
6
[Research advances in the pathogenesis of familial Kawasaki disease].[家族性川崎病发病机制的研究进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Jul;20(7):594-597. doi: 10.7499/j.issn.1008-8830.2018.07.016.
7
Association of Thrombomodulin Gene C1418T Polymorphism with Susceptibility to Kawasaki Disease in Chinese Children.血栓调节蛋白基因 C1418T 多态性与中国儿童川崎病易感性的关联。
Dis Markers. 2018 Jun 12;2018:1064380. doi: 10.1155/2018/1064380. eCollection 2018.
8
Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012.儿童及青少年川崎病:2003年至2012年奥地利西部地区(蒂罗尔州)川崎病患者的临床资料
Pediatr Rheumatol Online J. 2014 Sep 2;12(1):37. doi: 10.1186/1546-0096-12-37.
9
Update of genetic susceptibility in patients with Kawasaki disease.川崎病患者遗传易感性的最新进展。
Korean J Pediatr. 2015 Mar;58(3):84-8. doi: 10.3345/kjp.2015.58.3.84. Epub 2015 Mar 20.
10
Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.2011 - 2012年日本川崎病的描述性流行病学:来自第22次全国性调查结果
J Epidemiol. 2015;25(3):239-45. doi: 10.2188/jea.JE20140089. Epub 2015 Feb 7.